• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Fast Radius Expands Leadership Team and Appoints New General Counsel and Chief Accounting Officer

    3/15/22 8:00:00 AM ET
    $BAX
    $CNHI
    $FSRD
    $GRPN
    Medical/Dental Instruments
    Health Care
    Construction/Ag Equipment/Trucks
    Industrials
    Get the next $BAX alert in real time by email

    CHICAGO, March 15, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD), a cloud manufacturing company, today announced it has named Erin Stone as General Counsel and Corporate Secretary, and James Erkenswick as Chief Accounting Officer. These leadership additions mark important milestones for Fast Radius' evolution as a publicly traded company. In her capacity as General Counsel and Corporate Secretary, Stone will serve as an important strategic and legal advisor to Fast Radius's board of directors and management and will oversee all legal and compliance matters for the company. In his role as Chief Accounting Officer, Erkenswick will have leadership over the preparation of all financial accounting, audit and internal controls matters, and the preparation of Fast Radius's external reporting materials.

    "Erin and Jim bring invaluable experience leading corporate governance and compliance for fast-growing, public companies, bringing additional expertise and leadership as we continue to scale our business in the near-term," said Lou Rassey, Co-Founder and CEO of Fast Radius. "They both possess an entrepreneurial spirit and proven cross-functional leadership ability. We are thrilled to have them join the Fast Radius leadership team."

    Stone has more than 15 years of legal experience working with technology-driven businesses and public companies. Prior to Fast Radius, Stone served as Vice President and Deputy General Counsel, Corporate and Securities at Groupon (NASDAQ:GRPN), where she was a key advisor and trusted partner to their executive team and Board of Directors. She also brings strong technical expertise in corporate governance and securities, and broad commercial experience from her tenure at Groupon and as a corporate partner at Winston and Strawn LLP.

    As Chief Accounting Officer, Erkenswick brings more than 20 years of accounting and finance experience for industrial companies, with deep knowledge of SEC reporting and GAAP compliance. Most recently, Erkenswick served as Vice President, Assistant Controller at Baxter International Inc. (NYSE:BAX), where he held positions leading financial reporting and corporate accounting. Prior to joining Baxter International, Erkenswick held accounting leadership positions at US LBM, CNH Industrial (NYSE:CNHI), and Ace Hardware.

    ABOUT FAST RADIUS

    Fast Radius, Inc. is a leading cloud manufacturing and digital supply chain company. The Fast Radius Cloud Manufacturing Platform™ provides software applications and manufacturing solutions that help engineers design, make, and fulfill commercial-grade parts, when and where they are needed. This enables companies to manufacture and ship parts easily, flexibly, and sustainably. Founded in 2017, Fast Radius, Inc. is headquartered in Chicago with offices in Atlanta, Louisville, and Singapore, and microfactories in Chicago and at the UPS Worldport facility in Louisville, KY. To learn more about Fast Radius and how its digital manufacturing capabilities are helping companies, please visit www.fastradius.com or connect with us on LinkedIn at www.linkedin.com/company/fastradius or Twitter @fastradius.

    CONTACT

    Kelly Smith

    MSL U.S.

    Kelly.smith@mslgroup.com;

    646-500-7654



    Primary Logo

    Get the next $BAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAX
    $CNHI
    $FSRD
    $GRPN

    CompanyDatePrice TargetRatingAnalyst
    Baxter International Inc.
    $BAX
    10/31/2025Buy → Hold
    Argus
    Baxter International Inc.
    $BAX
    8/4/2025$25.00Buy → Hold
    Stifel
    Baxter International Inc.
    $BAX
    8/1/2025$25.00Buy → Neutral
    Goldman
    Baxter International Inc.
    $BAX
    2/26/2025$42.00Buy
    Goldman
    Baxter International Inc.
    $BAX
    2/24/2025Hold → Buy
    Argus
    Baxter International Inc.
    $BAX
    2/20/2025$39.00Overweight
    Barclays
    Baxter International Inc.
    $BAX
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    Groupon Inc.
    $GRPN
    7/10/2024$22.00Outperform
    Northland Capital
    More analyst ratings

    $BAX
    $CNHI
    $FSRD
    $GRPN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Baxter International Inc.

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    12/3/25 4:04:17 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Chief Accounting Officer Netzly Kyle exercised 5,828 shares at a strike of $15.60 and covered exercise/tax liability with 1,708 shares, increasing direct ownership by 17% to 28,611 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    11/24/25 5:26:47 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Chief Accounting Officer Netzly Kyle exercised 6,935 shares at a strike of $22.52 and covered exercise/tax liability with 2,032 shares, increasing direct ownership by 25% to 24,491 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    9/23/25 5:59:19 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Harinstein Jason bought $159,150 worth of shares (15,000 units at $10.61), increasing direct ownership by 37% to 55,658 units (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    8/9/24 4:38:58 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Senkypl Dusan bought $3,069,745 worth of shares (323,344 units at $9.49) (SEC Form 4)

    4 - Groupon, Inc. (0001490281) (Issuer)

    11/20/23 6:27:56 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    SEC Filings

    View All

    Groupon Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Groupon, Inc. (0001490281) (Filer)

    12/8/25 8:20:23 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    12/4/25 4:15:43 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    11/25/25 4:45:37 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Baxter downgraded by Argus

    Argus downgraded Baxter from Buy to Hold

    10/31/25 8:47:22 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Stifel with a new price target

    Stifel downgraded Baxter from Buy to Hold and set a new price target of $25.00

    8/4/25 8:18:58 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Goldman with a new price target

    Goldman downgraded Baxter from Buy to Neutral and set a new price target of $25.00

    8/1/25 8:11:11 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes. Title of Security CUSIP Number(1) Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fixed Spread Early Tender Payment (3)(4) Total Consideration(3)(4) 2.600% Senior Unsecured Notes due 2026 071813BQ1 $750,000,000 UST 1.500% due Aug. 15, 2026 FIT3 3.713% +30 bps $30

    12/4/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    INVESTIGATION ALERT: Berger Montague PC Investigates Baxter International Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: BAX)

    PHILADELPHIA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of Baxter International Inc. ("Baxter" or the "Company") (NYSE:BAX) about an investigation into Baxter's Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Baxter's marketing and sale of its Novum Large Volume Pump ("Novum LVP"). Shareholders of Baxter may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@bergermontague.com or (332) 271-8908, or Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or CLICK HERE. Berger Montague's investigation is focused on whether Baxter's Bo

    12/4/25 11:12:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amended by the Company's press release dated Nov. 19, 2025 (as it may be further amended or supplemented from time to time, the "Offer to Purchase"). The tender offers comprise Baxter's offer to purchase for cash (a) any and all of its 2.600% senior unsecured notes due 2026 (the "2026 Notes") (the "Any and All Tender Offer") and (b) a portion of its 1.9

    12/4/25 7:51:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Leadership Updates

    Live Leadership Updates

    View All

    Baxter Appoints Andrew Hider Chief Executive Officer

    Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

    7/7/25 8:35:00 AM ET
    $ATS
    $BAX
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Amerant Bancorp Announces Appointment of Two New Board Members

    Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management. "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high pe

    6/24/25 9:20:00 AM ET
    $AMTB
    $BAX
    $WBS
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care

    CNH announces Global Leadership Team appointment

    CNH announces Global Leadership Team appointment Basildon, March 17, 2025 CNH (NYSE:CNH) today announces the appointment of Cameron Batten as Chief Communications Officer effective March 31, 2025. Mr. Batten will join the Company's Global Leadership Team (GLT), which is empowered to carry out the fast and effective delivery of CNH's strategic priorities for profitable long-term growth. Cameron Batten has over 25 years of experience in communications across media and institutional/government relations, brand marketing, corporate reputation, employee engagement and social impact with top-tier consumer brands. Ahead of joining CNH, he served as Chief Communications Officer at Volkswage

    3/17/25 4:30:00 PM ET
    $CNH
    $CNHI
    Construction/Ag Equipment/Trucks
    Industrials

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Financials

    Live finance-specific insights

    View All

    Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes. Title of Security CUSIP Number(1) Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fixed Spread Early Tender Payment (3)(4) Total Consideration(3)(4) 2.600% Senior Unsecured Notes due 2026 071813BQ1 $750,000,000 UST 1.500% due Aug. 15, 2026 FIT3 3.713% +30 bps $30

    12/4/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amended by the Company's press release dated Nov. 19, 2025 (as it may be further amended or supplemented from time to time, the "Offer to Purchase"). The tender offers comprise Baxter's offer to purchase for cash (a) any and all of its 2.600% senior unsecured notes due 2026 (the "2026 Notes") (the "Any and All Tender Offer") and (b) a portion of its 1.9

    12/4/25 7:51:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced that it has increased the maximum purchase price for its $1.45 billion aggregate principal amount outstanding of 1.915% Senior Unsecured Notes due 2027 (the "2027 Notes") that it can repurchase under its previously announced cash tender offer for the 2027 Notes (the "2027 Notes Tender Offer") from $300 million to $600 million, on the terms and subject to the conditions set forth in the related Offer to Purchase dated Nov. 19, 2025 (the "Offer to Purchase"). The terms of the previously announced cash tender offer by Baxter for its 2.600% Senior Unsecured Notes due 2026 (the "2026 Notes Tender Offer" and, togethe

    11/19/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Groupon Inc.

    SC 13G/A - Groupon, Inc. (0001490281) (Subject)

    11/14/24 6:51:01 PM ET
    $GRPN
    Advertising
    Consumer Discretionary